1h Free Analyst Time
The rosacea treatment market is forecasted to grow by USD 744.29 mn during 2023-2028, accelerating at a CAGR of 6.2% during the forecast period. The report on the rosacea treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing focus on personalized treatment approaches, growing awareness of rosacea leading to better diagnosis, and rising number of strategies undertaken by market vendors.
The rosacea treatment market is segmented as below:
By Distribution Channel
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
By Route Of Administration
- Topical
- Oral
- Injectable
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the rosacea treatment market covers the following areas:
- Rosacea treatment market sizing
- Rosacea treatment market forecast
- Rosacea treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Distribution Channel
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global rosacea treatment market: AbbVie Inc., Aclaris Therapeutics Inc., AKUMS, Bausch Health Companies Inc., Croda International Plc, Dermata Therapeutics Inc., Galderma SA, Glenmark Pharmaceuticals Ltd., Hovione, Journey Medical Corp., LEO Pharma AS, Lupin Ltd., Maruho Co. Ltd., Mayne Pharma Group Ltd., Pfizer Inc., PruGen LLC, Sol-Gel Technologies Ltd., Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Zydus Lifesciences Ltd..Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising demand for cosmetic procedures.'
According to the report, one of the major drivers for this market is the growing focus on personalized treatment approaches.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Aclaris Therapeutics Inc.
- AKUMS
- Bausch Health Companies Inc.
- Croda International Plc
- Dermata Therapeutics Inc.
- Galderma SA
- Glenmark Pharmaceuticals Ltd.
- Hovione
- Journey Medical Corp.
- LEO Pharma AS
- Lupin Ltd.
- Maruho Co. Ltd.
- Mayne Pharma Group Ltd.
- Pfizer Inc.
- PruGen LLC
- Sol-Gel Technologies Ltd.
- Taro Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Zydus Lifesciences Ltd.
